Zura Bio ZURA
NASDAQ ZURA
$1.43 +0.02 (+1.78%)
At close: Nov 11, 2026 · 4:00 PM EST

Zura Bio (ZURA) Preferred Stock Liabilities (2021 - 2023)

Updated

Zura Bio (ZURA) recorded Preferred Stock Liabilities of $12.5 million in Q4 2022, down 91.0% from $139.38 million a year earlier and down 91.1% from the prior quarter.

Analysis

Zura Bio (ZURA) Preferred Stock Liabilities (2021 - 2023) Analysis & Trends

Starting with Q4 2021, Zura Bio's Preferred Stock Liabilities history includes 5 quarters.

  • Across earlier years, Preferred Stock Liabilities came in at $139.38 million in FY2021.
  • Per Business Quant, the preceding three quarters came in at $140.18 million (Q3 2022), $139.5 million (Q2 2022) and $139.38 million (Q1 2022).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Preferred Stock Liabilities (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Zura Bio 178.80 Mn -549.04 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2023 12.50 Mn
Sep 30, 2023 12.50 Mn
Jun 30, 2023 12.50 Mn
Mar 31, 2023 12.50 Mn
Dec 31, 2022 12.50 Mn
Sep 30, 2022 140.18 Mn
Jun 30, 2022 139.50 Mn
Mar 31, 2022 139.38 Mn
Dec 31, 2021 139.38 Mn
Sep 30, 2021 139.38 Mn
API Access

Zura Bio Preferred Stock Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=preferred-stock-liabilities&ticker=ZURA&period=max&api_key=YOUR_API_KEY